Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.07
+0.62 (0.75%)
At close: Nov 3, 2025, 4:00 PM EST
82.03
-1.04 (-1.26%)
After-hours: Nov 3, 2025, 7:57 PM EST
Edwards Lifesciences (EW) Revenue by Segment
History
| Date | Transcatheter Aortic Valve Replacement | Surgical Structural Heard | Critical Care | Transcatheter Mitral and Tricuspid Therapies |
|---|---|---|---|---|
| Mar 31, 2025 | 4.14B | 968.60M | 957.50M | 445.90M |
| Dec 31, 2024 | 4.11B | 966.10M | 928.10M | 394.40M |
| Sep 30, 2024 | 4.05B | 981.30M | 902.60M | 352.10M |
| Jun 30, 2024 | 3.99B | 1.02B | 888.90M | 303.00M |
| Mar 31, 2024 | 3.94B | 1.03B | 864.80M | 264.30M |
| Dec 31, 2023 | 3.88B | 1.02B | 855.00M | 228.90M |
| Sep 30, 2023 | 3.77B | 999.30M | 841.60M | 197.60M |
| Jun 30, 2023 | 3.67B | 975.20M | 847.00M | 173.10M |
| Mar 31, 2023 | 3.58B | 948.30M | 851.40M | 150.40M |
| Dec 31, 2022 | 3.52B | 920.50M | 834.90M | 130.70M |
| Sep 30, 2022 | 3.52B | 893.10M | 821.50M | 116.10M |
| Jun 30, 2022 | 3.52B | 890.30M | 789.70M | 109.90M |
| Mar 31, 2022 | 3.51B | 888.00M | 738.40M | 102.50M |
| Dec 31, 2021 | 3.42B | 896.90M | 725.40M | 96.70M |
| Sep 30, 2021 | 3.33B | 889.10M | - | 86.00M |
| Jun 30, 2021 | 3.21B | 872.00M | - | 73.80M |
| Mar 31, 2021 | 2.91B | 857.90M | - | 63.60M |
| Dec 31, 2020 | 2.86B | 781.40M | - | 47.60M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.